ArticleFrontiers in pharmacology2024

QL1604 combined with bevacizumab as an innovative first-line treatment for HCC patient with extensive metastasis who showed remarkable effect: a case report.

Yanzhi Wan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.